MHMAD AHMAD
AGIL ABDALLA
CATEDRÁTICO DE UNIVERSIDAD
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)
2024
-
Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 172
-
Corrigendum to “Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats” [Biomed. Pharmacother. 172 (2024) 116314] (Biomedicine & Pharmacotherapy (2024) 172, (S0753332224001951), (10.1016/j.biopha.2024.116314))
Biomedicine and Pharmacotherapy
2023
2019
-
Diet quality index as a predictor of treatment efficacy in overweight and obese adolescents: The EVASYON study
Clinical Nutrition, Vol. 38, Núm. 2, pp. 782-790
2015
-
Maternal PPARG Pro12Ala polymorphism is associated with infant's neurodevelopmental outcomes at 18months of age
Early Human Development, Vol. 91, Núm. 8, pp. 457-462